ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

Lundbeck Foundation’s new grant strategy puts talent and the brain first
17. September 2018
DNA detectives expose the little devils responsible for diverticular disease
3. September 2018
Participate in The Brain Prize Meeting on Dementia
30. August 2018